Lin and colleagues recently demonstrated that ST3GAL1-mediated O-linked sialylation of CD55, an important complement regulatory protein, acts like an immune checkpoint molecule for breast cancer cells to evade immune attack. The gene discussed is CD55; the disease is breast carcinoma.